Novartis Ag (NVS) Shares Outstanding (2009 - 2026)

Novartis Ag has reported Shares Outstanding (Entity) for 18 years, with the latest figure at $952.5 million in Q2 2026.

• Quarterly Shares Outstanding (Entity) fell 2.21% year-over-year to $952.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $952.5 million (down 2.21% YoY) and the FY2025 annual result came in at $969.5 million, down 3.91% from the prior year.
• Shares Outstanding (Entity) slipped to $952.5 million in Q2 2026 per NVS's latest filing, from $969.5 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $1.1 billion in Q2 2022 and troughed at $952.5 million in Q2 2026.
• A 5-year average of $1.0 billion and a median of $1.0 billion in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) fell 2.01% in 2022, then retreated 5.23% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $1.1 billion in 2022, then dropped by 4.77% to $1.0 billion in 2023, then declined by 2.84% to $1.0 billion in 2024, then retreated by 3.91% to $969.5 million in 2025, then fell by 1.75% to $952.5 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $952.5 million, $969.5 million, and $974.0 million for Q2 2026, Q4 2025, and Q2 2025 respectively.